Conflict of interest appears in NSA drug hearing

One of the judges, who examined the current complaints of the importers, is Ewa Wrzesińska-Jóźków, who was the deputy president of the Main Customs Office (GUC) between December 12, 2001 and April 30, 2002, and therefore was also the individual responsible for issuing ordinances which were the unfavorable for the pharmaceutical importers. Zbigniew Bujak, who was the the president of GUC during that time, made a public announcement in which he accused the companies of inflating the value of the imported drugs and therefore breaking regulations concerning sale margins. This allegedly led to the fact that the state budget did not receive zł. 5 billion in due tax. This accusation was strongly supported by Ewa Wrzesińska-Jóźków. GlaxoSmithKline, the largest investor in the pharmaceutical sector, has submitted a motion to the NSA with a request to remove her from the judges hearing the case. (Puls Biznesu, pp. 1, 4) A.K.